Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,252 | 3,252 | 26,481 | 41,712 | 70,073 |
| Inventories | 22,287 | 8,269 | N/A | N/A | N/A |
| TOTAL | $27,935 | $14,221 | $34,370 | $44,564 | $72,814 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 1 | 4 | 7 |
| Investments And Advances | 38 | 38 | 38 | 38 | 38 |
| Intangibles | 9,347 | 9,347 | 9,347 | 9,347 | 9,347 |
| Other Non-Current Assets | 93,619 | 93,046 | 59,854 | 60,046 | 60,223 |
| TOTAL | $103,004 | $102,431 | $69,241 | $69,435 | $69,615 |
| Total Assets | $130,938 | $116,652 | $103,611 | $113,999 | $142,429 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,694 | 4,927 | 2,927 | 1,165 | 1,277 |
| Accrued Expenses | 7,483 | 2,246 | 2,633 | 3,168 | 2,528 |
| Other current liabilities | 22,650 | 28,400 | N/A | N/A | N/A |
| TOTAL | $44,915 | $35,815 | $5,779 | $4,530 | $3,982 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,031 | 308 | 263 | 481 | 678 |
| TOTAL | $8,496 | $6,735 | $6,401 | $6,043 | $5,664 |
| Total Liabilities | $53,410 | $42,550 | $12,180 | $10,573 | $9,646 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,763 | 7,727 | 6,359 | 5,848 | 5,841 |
| Common Shares | 18 | 7 | 6 | 146 | 146 |
| Retained earnings | -238,804 | -201,370 | -162,231 | -129,689 | -96,048 |
| Other shareholders' equity | 9,977 | 4,024 | 600 | 600 | 600 |
| TOTAL | $77,528 | $74,102 | $91,432 | $103,426 | $132,783 |
| Total Liabilities And Equity | $130,938 | $116,652 | $103,611 | $113,999 | $142,429 |